| Product Code: ETC8861480 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Drug Discovery Outsourcing Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Drug Discovery Outsourcing Market - Industry Life Cycle |
3.4 Poland Drug Discovery Outsourcing Market - Porter's Five Forces |
3.5 Poland Drug Discovery Outsourcing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Poland Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Molecule, 2021 & 2031F |
3.7 Poland Drug Discovery Outsourcing Market Revenues & Volume Share, By Discovery Approach, 2021 & 2031F |
3.8 Poland Drug Discovery Outsourcing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Poland Drug Discovery Outsourcing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Poland Drug Discovery Outsourcing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Poland Drug Discovery Outsourcing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on research and development activities in the pharmaceutical industry |
4.2.2 Rising demand for specialized expertise and technologies in drug discovery |
4.2.3 Cost-saving benefits associated with outsourcing drug discovery processes |
4.3 Market Restraints |
4.3.1 Data security and confidentiality concerns related to outsourcing drug discovery |
4.3.2 Quality control challenges when working with external service providers |
4.3.3 Regulatory hurdles and compliance issues in outsourcing drug discovery activities |
5 Poland Drug Discovery Outsourcing Market Trends |
6 Poland Drug Discovery Outsourcing Market, By Types |
6.1 Poland Drug Discovery Outsourcing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Chemical Services, 2021- 2031F |
6.1.4 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Biology Services, 2021- 2031F |
6.2 Poland Drug Discovery Outsourcing Market, By Drug Molecule |
6.2.1 Overview and Analysis |
6.2.2 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Small Molecules, 2021- 2031F |
6.2.3 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Large Molecules, 2021- 2031F |
6.3 Poland Drug Discovery Outsourcing Market, By Discovery Approach |
6.3.1 Overview and Analysis |
6.3.2 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Empirical Drug Discovery, 2021- 2031F |
6.3.3 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Rational Drug Discovery, 2021- 2031F |
6.4 Poland Drug Discovery Outsourcing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Target Identification and Screening, 2021- 2031F |
6.4.3 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Lead Identification and Candidate Optimization, 2021- 2031F |
6.4.4 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Development of Disease Models, 2021- 2031F |
6.4.5 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Pre-formulation Studies, 2021- 2031F |
6.4.6 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Entire Clinical Trials, 2021- 2031F |
6.4.7 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Poland Drug Discovery Outsourcing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Anti-infective, 2021- 2031F |
6.5.3 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.5.4 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Central Nervous System, 2021- 2031F |
6.5.5 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.5.6 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Endocrine, 2021- 2031F |
6.5.7 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.5.8 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Poland Drug Discovery Outsourcing Market, By End-user |
6.6.1 Overview and Analysis |
6.6.2 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.6.3 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.6.4 Poland Drug Discovery Outsourcing Market Revenues & Volume, By Academic Institutes, 2021- 2031F |
7 Poland Drug Discovery Outsourcing Market Import-Export Trade Statistics |
7.1 Poland Drug Discovery Outsourcing Market Export to Major Countries |
7.2 Poland Drug Discovery Outsourcing Market Imports from Major Countries |
8 Poland Drug Discovery Outsourcing Market Key Performance Indicators |
8.1 Percentage of projects completed within specified timelines |
8.2 Client satisfaction scores with outsourced drug discovery services |
8.3 Number of successful drug discoveries attributed to outsourcing partnerships |
8.4 Percentage of cost savings achieved through outsourcing drug discovery |
8.5 Rate of technology adoption and innovation in outsourced drug discovery processes |
9 Poland Drug Discovery Outsourcing Market - Opportunity Assessment |
9.1 Poland Drug Discovery Outsourcing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Poland Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Molecule, 2021 & 2031F |
9.3 Poland Drug Discovery Outsourcing Market Opportunity Assessment, By Discovery Approach, 2021 & 2031F |
9.4 Poland Drug Discovery Outsourcing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Poland Drug Discovery Outsourcing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Poland Drug Discovery Outsourcing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Poland Drug Discovery Outsourcing Market - Competitive Landscape |
10.1 Poland Drug Discovery Outsourcing Market Revenue Share, By Companies, 2024 |
10.2 Poland Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here